BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 34713300)

  • 21. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 22. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR‑379‑5p inhibits cell proliferation and promotes cell apoptosis in non‑small cell lung cancer by targeting β‑arrestin‑1.
    Jiang Y; Zhu P; Gao Y; Wang A
    Mol Med Rep; 2020 Dec; 22(6):4499-4508. PubMed ID: 33173959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer.
    Wang L; Kong W; Liu B; Zhang X
    Biomed Pharmacother; 2018 Aug; 104():595-602. PubMed ID: 29803172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
    Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
    Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3 pathway.
    Shi J; Li J; Yang S; Hu X; Chen J; Feng J; Shi T; He Y; Mei Z; He W; Xie J; Li S; Jie Z; Tu S
    J Cell Physiol; 2020 Mar; 235(3):2891-2900. PubMed ID: 31602642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of LINC00346 inhibits proliferation of non-small cell lung cancer cells through mediating JAK-STAT3 signaling pathway.
    Wang F; Chen JG; Wang LL; Yan ZZ; Chen SP; Wang XG
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5135-5142. PubMed ID: 29228425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet isoform of phosphofructokinase promotes aerobic glycolysis and the progression of non‑small cell lung cancer.
    Wang F; Li L; Zhang Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells.
    Ge X; Peng X; Li M; Ji F; Chen J; Zhang D
    Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR‑454‑3p inhibits non‑small cell lung cancer cell proliferation and metastasis by targeting TGFB2.
    Liao H; Liang Y; Kang L; Xiao Y; Yu T; Wan R
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldolase A promotes proliferation and G
    Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
    Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer.
    Sha L; Lv Z; Liu Y; Zhang Y; Sui X; Wang T; Zhang H
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway.
    Peng W; He D; Shan B; Wang J; Shi W; Zhao W; Peng Z; Luo Q; Duan M; Li B; Cheng Y; Dong Y; Tang F; Zhang C; Duan C
    Cell Death Dis; 2019 Jul; 10(7):533. PubMed ID: 31296840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DHA inhibits invasion and metastasis in NSCLC cells by interfering with CCL18/STAT3 signaling pathway.
    Luo HQ; Huang YM; Li J; Tang XD; Chen R; Wang Y; Ren J; Dai QQ; Lan LB; Chen JY; Li XY
    Clin Exp Med; 2023 Oct; 23(6):2311-2320. PubMed ID: 36217054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.
    Wang X; Wang Y; Xiao G; Wang J; Zu L; Hao M; Sun X; Fu Y; Hu G; Wang J
    Oncotarget; 2016 May; 7(21):30350-64. PubMed ID: 27107418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis.
    Wei D; Sun L; Feng W
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
    Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
    Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ISLR affects colon cancer progression by regulating the epithelial-mesenchymal transition signaling pathway.
    Chi C; Liu T; Yang S; Wang B; Han W; Li J
    Anticancer Drugs; 2022 Jan; 33(1):e670-e679. PubMed ID: 34520435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
    Zhao L; Bi M; Zhang H; Shi M
    Cancer Biother Radiopharm; 2020 Jun; 35(5):362-370. PubMed ID: 32380843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.